semaglutide with vyvanse Wegovy® and Saxenda® are both GLP-1 medications designed to support weight care – but they're not the same. 👀 Weekly vs. daily injections 📉 Different trial outcomes 💊 Different active ingredients Not vyvanse and semaglutide Novo Nordisk,

At minimum, check for: A batch number that corresponds to the product The testing date The laboratorys name The amount tested An HPLC purity result Identity testing Sterility or endotoxin results when required A dated, batch-specific report is more useful than an undated example COA or a general company claim

Semaglutide is a relatively novel glucagon-like peptide-1 (GLP-1) receptor agonist that is currently approved to treat diabetes and promote weight loss in overweight and obese individuals

Your provider must verify your eligibility before planning any transition

By identifying your unique peptide pathway predispositions, PlexusDx providers can optimize your GLP-1 therapy to maximize both metabolic improvement and fertility outcomes